Class 2 Residual Solvents Determination: Methods, Limits, and Regulatory Compliance

Class 2 residual solvents determination verifies that restricted organic volatile solvents in pharmaceutical substances, excipients, and drug products remain within the safety limits defined by ICH Q3C and the harmonized pharmacopoeial chapters such as USP <467> and ChP 0861. Using static headspace gas chromatography with flame ionization detection (HS-GC-FID), accredited third-party laboratories quantify solvents such as methanol, acetonitrile, dichloromethane, toluene, and N-methylpyrrolidone down to low-ppm levels. This article explains the classification system, regulatory limits, analytical procedures, validation requirements, and typical applications of Class 2 residual solvent testing.

Technical Overview

Residual solvents are organic volatile chemicals that are used or produced in the synthesis of drug substances and excipients, or in the preparation of drug products, and that are not completely removed by practical manufacturing techniques such as drying, vacuum stripping, or crystallization. Because these solvents provide no therapeutic benefit and may carry toxicological risk, global regulators require their levels to be controlled within scientifically justified safety limits as part of pharmaceutical quality standards.

The ICH Q3C guideline classifies residual solvents into three categories based on risk to human health. Class 1 solvents are known or strongly suspected human carcinogens and environmental hazards that should be avoided. Class 3 solvents have low toxic potential and are generally limited to 5000 ppm or less. Class 2 solvents are those that must be limited in pharmaceutical products because they are non-genotoxic animal carcinogens, causative agents of other irreversible toxicity such as neurotoxicity or teratogenicity, or are suspected of significant but reversible toxicity. Class 2 residual solvents determination therefore focuses on accurately quantifying these restricted solvents and demonstrating compliance with their permitted daily exposure (PDE) values.

Regulatory Basis and Pharmacopoeial Standards

• ICH Q3C (Guideline for Residual Solvents), which defines the classification system and PDE values adopted by major regulatory authorities worldwide.
• USP General Chapter <467> (Residual Solvents), providing harmonized headspace GC procedures for the United States market.
• Ph. Eur. General Chapter 2.4.24 (Identification and Control of Residual Solvents), harmonized with the US and Japanese pharmacopoeias.
• Chinese Pharmacopoeia General Chapter 0861 (Residual Solvents Determination), the compendial method applied to products registered in China.
• ISO/IEC 17025, the general competence requirements applied by accredited third-party laboratories performing residual solvent analysis.

Permitted Daily Exposure and Concentration Limits

Each Class 2 solvent is assigned a PDE expressed in mg/day, derived from toxicological end points using appropriate safety factors. Concentration limits in ppm are calculated assuming a maximum daily intake of 10 g of drug product, known as ICH Q3C Option 1. Under Option 2, the actual maximum daily dose of the product may be used instead, which is particularly important when several Class 2 solvents are present simultaneously and the combined exposure must be justified.

Testing Samples

Active Pharmaceutical Ingredients (APIs)

APIs are the most commonly tested matrix, since final purification and drying operations directly determine residual solvent content. Testing is performed on registration batches, commercial batches, pilot lots, and process development samples to support specification setting and process control.

Drug Products and Finished Dosage Forms

Tablets, capsules, granules, pellets, films, and semi-solid formulations may retain solvents introduced by granulation, coating, or encapsulation processes. Samples are typically ground or homogenized before dissolution in the analytical diluent to ensure representative extraction.

Pharmaceutical Excipients and Raw Materials

Excipients manufactured by synthetic routes or processed with organic solvents, such as certain polymers, binders, and coatings, are evaluated as part of supplier qualification and incoming material control programs.

Intermediates, Starting Materials, and In-Process Controls

Monitoring intermediate stages of a synthesis helps identify where solvents accumulate, guides optimization of drying and crystallization steps, and supports quality-by-design approaches during process development.

Sample preparation depends on matrix solubility. Water-soluble samples are dissolved in water or a water-compatible diluent, while water-insoluble samples are typically dissolved in dimethyl sulfoxide (DMSO) or N,N-dimethylformamide (DMF) prior to headspace analysis. Samples must be tightly sealed in headspace vials to prevent loss of volatile analytes.

Testing Items

The testing scope is tailored to the synthetic route and formulation process of each product, based on solvents known or reasonably expected to be present. The most frequently monitored Class 2 solvents and their typical ICH Q3C concentration limits (Option 1) are listed below:

• Methanol — 3000 ppm
• Acetonitrile — 410 ppm
• Dichloromethane — 600 ppm
• Chloroform — 60 ppm
• Toluene — 890 ppm
• Xylene (ortho-, meta-, para-isomers) — 2170 ppm
• n-Hexane — 290 ppm
• Cyclohexane — 3880 ppm
• Pyridine — 200 ppm
• 1,4-Dioxane — 380 ppm
• N,N-Dimethylformamide — 880 ppm
• N,N-Dimethylacetamide — 1090 ppm
• N-Methylpyrrolidone — 530 ppm
• Ethylene glycol — 620 ppm
• 1,1,2-Trichloroethene — 80 ppm

Additional Class 2 solvents can be added to the target list based on process knowledge, including chlorobenzene (360 ppm), cumene (70 ppm), 1,2-dimethoxyethane (100 ppm), 2-ethoxyethanol (160 ppm), 2-methoxyethanol (100 ppm), formamide (220 ppm), methylbutyl ketone (290 ppm), methylcyclohexane (1180 ppm), nitromethane (550 ppm), sulfolane (160 ppm), tetralin (100 ppm), and 1,2-dichloroethene (1870 ppm). Screening for unknown volatile impurities can also be included as part of the analytical package.

Testing Methods

Static Headspace GC-FID — The Primary Compendial Procedure

Static headspace gas chromatography with flame ionization detection is the reference technique for volatile Class 2 solvents and forms the basis of the harmonized compendial procedures. The sample is dissolved in a suitable diluent, sealed in a headspace vial, and equilibrated at an elevated temperature (commonly 80 °C for approximately 60 minutes) so that the volatile solvents partition into the headspace gas phase. An aliquot of the vapor phase is then injected into the GC, typically equipped with a G43-type capillary column (6% cyanopropylphenyl and 94% dimethylpolysiloxane phase) and a temperature program starting near 40 °C and ramping to approximately 240 °C. This approach corresponds to Procedure A of USP <467> and the primary method of ChP 0861 and Ph. Eur. 2.4.24.

Confirmation and Alternative Conditions

When a peak exceeds its limit or resolution is inadequate, confirmation is performed on a column of different polarity, typically a G16-type polyethylene glycol column, in accordance with Procedure B. If neither compendial condition adequately resolves or quantifies the target analytes, Procedure C permits validated modifications such as adjusted oven programs, column dimensions, or diluent systems, provided system suitability and full validation criteria are satisfied.

Direct Injection GC for Low-Volatility Solvents

Class 2 solvents with high boiling points or poor headspace response, such as formamide, ethylene glycol, N-methylpyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide, and sulfolane, are quantified by direct liquid injection GC-FID, frequently employing a polar column, because headspace enrichment alone does not provide sufficient sensitivity for these compounds.

GC-MS Identification of Unknown Peaks

When unidentified volatile peaks are observed in the chromatogram, gas chromatography coupled with mass spectrometry (GC-MS) is used for structural confirmation against certified reference standards and spectral libraries. Once identified, the compound can be incorporated into the quantitative method with the corresponding standard.

Quantification Strategy and Method Validation

Quantification is performed by external calibration using certified reference standards; standard addition may be applied where matrix effects are significant. Full validation in accordance with ICH Q2(R2) and compendial verification requirements typically covers:

• Specificity, including resolution from matrix interferences and co-eluting peaks
• Linearity across the reportable range, generally from the reporting threshold to well above the specification limit
• Accuracy and recovery at multiple spiked levels, commonly 50%, 100%, and 150% of the limit
• Repeatability and intermediate precision
• Limit of detection and limit of quantification sufficiently below the ppm specification
• Robustness to small variations in equilibration temperature, equilibration time, and diluent composition
• System suitability criteria for resolution, peak symmetry, and replicate injection precision

Applications

Class 2 residual solvents determination supports the full product lifecycle in the pharmaceutical and fine chemical industries:

• Batch release testing of APIs, excipients, and finished drug products against registered specifications
• Regulatory submissions such as DMF, ANDA, NDA, and CEP dossiers, where residual solvent data form part of the CMC documentation
• Process development and optimization, including comparison of crystallization, washing, and drying strategies for effective solvent removal
• Out-of-specification and deviation investigations, including root-cause analysis of unexpected volatile impurities
• Cleaning validation studies and quality control of recovered or recycled solvents in GMP environments
• Stability programs monitoring changes in residual solvent levels during storage
• Supplier qualification and incoming-material control for purchased intermediates and raw materials

For products containing multiple Class 2 solvents, the data also support an Option 2 compliance argument, in which the sum of the ratios of measured exposure to each solvent PDE is demonstrated to be no greater than one.

FAQ

What are Class 2 residual solvents?

Class 2 residual solvents are organic volatile solvents that must be restricted in pharmaceutical products because they are associated with irreversible toxicity, such as carcinogenicity, neurotoxicity, or teratogenicity, or with significant reversible toxicity. Their permitted levels are defined by PDE values in ICH Q3C and adopted in the harmonized pharmacopoeial chapters.

How do Class 2 solvents differ from Class 1 and Class 3 solvents?

Class 1 solvents are known or suspected human carcinogens and should be avoided entirely; Class 2 solvents must be limited to defined ppm or PDE-based levels; Class 3 solvents have low toxic potential and are generally acceptable at levels up to 5000 ppm, subject to justification.

Which analytical method is used for Class 2 residual solvents determination?

The standard approach is static headspace gas chromatography with flame ionization detection following the harmonized procedures of USP <467>, Ph. Eur. 2.4.24, and ChP 0861. Direct injection GC and GC-MS are used as supplements for low-volatility solvents and unknown peak identification, respectively.

How are limits handled when several Class 2 solvents are present?

Under ICH Q3C Option 2, the combined exposure is acceptable if the sum of each solvent concentration divided by its respective concentration limit (calculated from the actual daily dose) does not exceed one. This approach avoids unnecessarily strict individual limits for low-dose products.

What sample quantity is required for testing?

Typically, a few hundred milligrams to approximately one gram of homogenized sample per determination is sufficient, depending on the method and the number of target solvents. Samples should be shipped in tightly sealed containers to prevent loss of volatile components.

When is direct injection preferred over headspace injection?

Direct liquid injection is preferred for high-boiling, poorly volatile Class 2 solvents such as formamide, ethylene glycol, N-methylpyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide, and sulfolane, because these compounds partition inefficiently into the headspace phase.

How are results reported?

Results are reported for each individual solvent in ppm (or mg/g), compared directly against the applicable ICH Q3C or pharmacopoeial limit, with the method, diluent, and validation status clearly documented for regulatory use.

Can the results be used for global regulatory submissions?

Yes. When testing is performed by accredited third-party laboratories using validated compendial methods in compliance with ISO/IEC 17025 and GMP data integrity expectations, the resulting data are widely accepted in support of international filings and batch release decisions.